Operating Income - Novogene Co Ltd (SSE:688315) - Alpha Spread

Novogene Co Ltd
SSE:688315

Watchlist Manager
Novogene Co Ltd Logo
Novogene Co Ltd
SSE:688315
Watchlist
Price: 9.45 CNY -3.67% Market Closed
Market Cap: 3.9B CNY
Have any thoughts about
Novogene Co Ltd?
Write Note

Novogene Co Ltd
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Novogene Co Ltd
Operating Income Peer Comparison

Comparables:
603259
300759
2269
300347
1548

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Novogene Co Ltd
SSE:688315
Operating Income
ÂĄ183.8m
CAGR 3-Years
55%
CAGR 5-Years
12%
CAGR 10-Years
N/A
WuXi AppTec Co Ltd
SSE:603259
Operating Income
ÂĄ10.6B
CAGR 3-Years
37%
CAGR 5-Years
38%
CAGR 10-Years
N/A
Pharmaron Beijing Co Ltd
SZSE:300759
Operating Income
ÂĄ1.6B
CAGR 3-Years
5%
CAGR 5-Years
25%
CAGR 10-Years
N/A
WuXi Biologics (Cayman) Inc
HKEX:2269
Operating Income
ÂĄ3.7B
CAGR 3-Years
9%
CAGR 5-Years
33%
CAGR 10-Years
N/A
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
Operating Income
ÂĄ1.5B
CAGR 3-Years
13%
CAGR 5-Years
20%
CAGR 10-Years
30%
Genscript Biotech Corp
HKEX:1548
Operating Income
-$395m
CAGR 3-Years
-12%
CAGR 5-Years
-51%
CAGR 10-Years
N/A

See Also

What is Novogene Co Ltd's Operating Income?
Operating Income
183.8m CNY

Based on the financial report for Dec 31, 2023, Novogene Co Ltd's Operating Income amounts to 183.8m CNY.

What is Novogene Co Ltd's Operating Income growth rate?
Operating Income CAGR 5Y
12%

Over the last year, the Operating Income growth was -13%. The average annual Operating Income growth rates for Novogene Co Ltd have been 55% over the past three years , 12% over the past five years .

Back to Top